To explore the contribution of common ccRCC driver mutations (such as VHL, TP53, BAP1, PBRM1, and SETD2) in case #22, four different areas of the primary tumor were analyzed by WES and compared to its derivative cell line (Fig. 1e). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.